These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 33459645)

  • 1. A Retrospective Study on the Benefits of Combined Citicoline, Memantine, and Acetylcholinesterase Inhibitor Treatments in Older Patients Affected with Alzheimer's Disease.
    Castagna A; Fabbo A; Manzo C; Lacava R; Ruberto C; Ruotolo G
    J Alzheimers Dis; 2021; 79(4):1509-1515. PubMed ID: 33459645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Citicholinage Study: Citicoline Plus Cholinesterase Inhibitors in Aged Patients Affected with Alzheimer's Disease Study.
    Gareri P; Castagna A; Cotroneo AM; Putignano D; Conforti R; Santamaria F; Marino S; Putignano S
    J Alzheimers Dis; 2017; 56(2):557-565. PubMed ID: 28035929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The CITIMERIVA Study: CITIcoline plus MEmantina plus RIVAstigmine in Older Patients Affected with Alzheimer's Disease.
    Castagna A; Manzo C; Fabbo A; Lacava R; Ruberto C; Ruotolo G
    Clin Drug Investig; 2021 Feb; 41(2):177-182. PubMed ID: 33484469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retrospective study on the benefits of combined Memantine and cholinEsterase inhibitor treatMent in AGEd Patients affected with Alzheimer's Disease: the MEMAGE study.
    Gareri P; Putignano D; Castagna A; Cotroneo AM; De Palo G; Fabbo A; Forgione L; Giacummo A; Lacava R; Marino S; Simone M; Zurlo A; Putignano S
    J Alzheimers Dis; 2014; 41(2):633-40. PubMed ID: 24643135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Citicoline: A Cholinergic Precursor with a Pivotal Role in Dementia and Alzheimer's Disease.
    Gareri P; Cotroneo AM; Montella R; Gaglianone M; Putignano S
    J Alzheimers Dis; 2024; 100(2):725-733. PubMed ID: 38905051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The CITIRIVAD Study: CITIcoline plus RIVAstigmine in Elderly Patients Affected with Dementia Study.
    Castagna A; Cotroneo AM; Ruotolo G; Gareri P
    Clin Drug Investig; 2016 Dec; 36(12):1059-1065. PubMed ID: 27587069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Citicoline as an Adjunct Treatment for Alzheimer's Disease: A Systematic Review.
    Piamonte BLC; Espiritu AI; Anlacan VMM
    J Alzheimers Dis; 2020; 76(2):725-732. PubMed ID: 32538854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Overview of Combination Treatment with Citicoline in Dementia.
    Gareri P; Veronese N; Cotroneo AM
    Rev Recent Clin Trials; 2022; 17(1):4-8. PubMed ID: 34939548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The CITIMEM study: A pilot study. Optimizing pharmacological treatment in dementia.
    Gareri P; Cotroneo AM; Orsitto G; Putignano S
    Arch Gerontol Geriatr; 2020; 89():104073. PubMed ID: 32447126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness and safety of citicoline in mild vascular cognitive impairment: the IDEALE study.
    Cotroneo AM; Castagna A; Putignano S; Lacava R; Fantò F; Monteleone F; Rocca F; Malara A; Gareri P
    Clin Interv Aging; 2013; 8():131-7. PubMed ID: 23403474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monotherapy Is Good Enough for Patients with Mild-to-Moderate Alzheimer's Disease: A Network Meta-analysis of 76 Randomized Controlled Trials.
    Tsoi KK; Chan JY; Chan FC; Hirai HW; Kwok TC; Wong SY
    Clin Pharmacol Ther; 2019 Jan; 105(1):121-130. PubMed ID: 29717478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-utility analysis of memantine extended release added to cholinesterase inhibitors compared to cholinesterase inhibitor monotherapy for the treatment of moderate-to-severe dementia of the Alzheimer's type in the US.
    Saint-Laurent Thibault C; Özer Stillman I; Chen S; Getsios D; Proskorovsky I; Hernandez L; Dixit S
    J Med Econ; 2015; 18(11):930-43. PubMed ID: 26086535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Memantine and Acetylcholinesterase Inhibitor Use in Alzheimer's Disease Clinical Trials: Potential for Confounding by Indication.
    Huisa BN; Thomas RG; Jin S; Oltersdorf T; Taylor C; Feldman HH
    J Alzheimers Dis; 2019; 67(2):707-713. PubMed ID: 30636733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Importance of Citicoline in Combined Treatment in Dementia: What did the Citimem Study Teach us?
    Gareri P; Cotroneo AM; Orsitto G; Putignano S
    Rev Recent Clin Trials; 2021; 16(2):126-130. PubMed ID: 33243132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinical and cost-effectiveness of donepezil, rivastigmine, galantamine and memantine for Alzheimer's disease.
    Loveman E; Green C; Kirby J; Takeda A; Picot J; Payne E; Clegg A
    Health Technol Assess; 2006 Jan; 10(1):iii-iv, ix-xi, 1-160. PubMed ID: 16409879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Asthma and Chronic Obstructive Pulmonary Disease as a Comorbidity and Association with the Choice of Antidementia Medication Among Persons with Alzheimer's Disease.
    Lampela P; Tolppanen AM; Koponen M; Tanskanen A; Tiihonen J; Hartikainen S; Taipale H
    J Alzheimers Dis; 2020; 73(3):1243-1251. PubMed ID: 31929157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acetylcholinesterase inhibitors and sleep architecture in patients with Alzheimer's disease.
    Cooke JR; Loredo JS; Liu L; Marler M; Corey-Bloom J; Fiorentino L; Harrison T; Ancoli-Israel S
    Drugs Aging; 2006; 23(6):503-11. PubMed ID: 16872233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Memantine and acetylcholinesterase inhibitor treatment in cases of CDR 0.5 or questionable impairment.
    McClendon MJ; Hernandez S; Smyth KA; Lerner AJ
    J Alzheimers Dis; 2009; 16(3):577-83. PubMed ID: 19276552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential efficacy of treatment with acetylcholinesterase inhibitors in patients with mild and moderate Alzheimer's disease over a 6-month period.
    López-Pousa S; Turon-Estrada A; Garre-Olmo J; Pericot-Nierga I; Lozano-Gallego M; Vilalta-Franch M; Hernández-Ferràndiz M; Morante-Muñoz V; Isern-Vila A; Gelada-Batlle E; Majó-Llopart J
    Dement Geriatr Cogn Disord; 2005; 19(4):189-95. PubMed ID: 15677866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is memantine + acetylcholinesterase inhibitor treatment superior to either therapy alone in Alzheimer's disease?
    Mattace-Raso F
    J Alzheimers Dis; 2014; 41(2):641-2. PubMed ID: 24748117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.